US Senior Medical Director – Early Assets, Immunology

AstraZeneca • Wilmington, DE

1d • Hybrid

About The Position

Are you ready to turn ideas into life-changing medicines? At AstraZeneca, we are committed to addressing the unmet needs of patients worldwide through scientific innovation. As a Senior Medical Director, Immunology Early Assets, you will play a crucial role in leveraging our scientific capabilities to positively impact patients' lives. Reporting directly to the US Medical Head, Immunology, you will lead the development of ambitious US medical strategies for our early pipeline of immunology products, including cell therapies. This is an opportunity to seize, design, and influence across a complex matrix system to ensure US needs are integrated into global development plans. Accountabilities: As a strategic leader, you will shape the scientific and medical direction for novel therapies (e.g. cell therapies), ensuring alignment with pipeline priorities and business objectives - while supporting efforts on lifecycle management of current in-line assets. You will serve as the internal medical expert for emerging assets, collaborating cross-functionally with global teams and external partners. You will partner with global medical and R&D to ensure robust translational and early clinical development plans, incorporating medical insights and real-world data opportunities. Your role will involve crafting compelling scientific narratives, developing solutions for outstanding product launches, and optimizing evidence activities to support practice change initiatives. You will also ensure comprehensive external engagement plans and play an integral role in medical advisory boards.

Requirements

• Doctoral level degree: MD, PhD, or PharmD
• 5+ years of experience in the pharmaceutical industry (medical, marketing, R&D, market access roles), or working in a relevant health system setting (clinical, pharmacy, pathway design etc.)
• Deep medical, clinical or scientific expertise in immunology and/or cell therapy
• Experienced business leader able to deliver results in a complex matrix environment
• US regulatory strategy knowledge including product approval, label requirements/negotiation
• Proven ability to build internal/external networks and to collaborate internally/externally
• Substantial evidence generation/data expertise, e.g. clinical trial experience (conducted Ph2, Ph3 or Ph4 studies), and/or substantial RWE experience

Nice To Haves

• Global and/or R&D experience, or proven track record of supporting early asset or first-in-class product development
• Relevant experience beyond medical affairs (e.g. in a marketing/R&D/market access role)

Responsibilities

• Shape the scientific and medical direction for novel therapies (e.g. cell therapies), ensuring alignment with pipeline priorities and business objectives - while supporting efforts on lifecycle management of current in-line assets.
• Serve as the internal medical expert for emerging assets, collaborating cross-functionally with global teams and external partners.
• Partner with global medical and R&D to ensure robust translational and early clinical development plans, incorporating medical insights and real-world data opportunities.
• Craft compelling scientific narratives, developing solutions for outstanding product launches, and optimizing evidence activities to support practice change initiatives.
• Ensure comprehensive external engagement plans and play an integral role in medical advisory boards.

What This Job Offers

• Job Type: Full-time
• Career Level: Mid Level
• Education Level: Ph.D. or professional degree
• Number of Employees: 5,001-10,000 employees